ArticleStem cell research & therapy2026

Splice-altering TP53 missense mutations as drivers of dysfunction and targets for RNA-based therapy.

Sun-Ku Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.